Methanol → HCID 131735024, compound

HRID 926623Notes

Reaction equation

HRID 926623 reaction equation
[CH2:1]([C:8]1[C:9](Cl)=[N:10][C:11]2[C:16]([C:17]=1[Cl:18])=[CH:15][C:14]([C:19]([C:31]1[N:35]([CH3:36])[CH:34]=[N:33][CH:32]=1)([C:21]1[CH:22]=[N:23][C:24]([C:27]([F:30])([F:29])[F:28])=[CH:25][CH:26]=1)[OH:20])=[CH:13][CH:12]=2)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[C:38]([OH:44])([C:40]([F:43])([F:42])[F:41])=[O:39].C[O-].[Na+].CO>>[CH2:1]([C:8]1[C:9]([O:39][CH3:38])=[N:10][C:11]2[C:16]([C:17]=1[Cl:18])=[CH:15][C:14]([C:19]([C:31]1[N:35]([CH3:36])[CH:34]=[N:33][CH:32]=1)([C:21]1[CH:22]=[N:23][C:24]([C:27]([F:30])([F:29])[F:28])=[CH:25][CH:26]=1)[OH:20])=[CH:13][CH:12]=2)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[C:38]([OH:44])([C:40]([F:43])([F:42])[F:41])=[O:39]

Participants

4

Reactant 3

HCID 887Methanol2×HCID 10942334Sodium Methoxide2×HCID 131735025HCID 131735025, compound

Product 1

HCID 131735024HCID 131735024, compound

Conditions

Temperature
53 °C

Procedure

A mixture of (3-benzyl-2,4-dichloroquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)(6-(trifluoromethyl)pyridin-3-yl)methanol (1.10 g, 2.02 mmol, Example 109) and 0.5 M NaOMe in MeOH (13 mL, 6.5 mmol) in a sealed tube was heated at 53° C. for 1 hour. More 0.5 M NaOMe in MeOH (6.5 mL, 3.3 mmol) was added, and the mixture was stirred at the same temperature for another 5 hours. The solvent was evaporated in vacuo, and the residue was diluted with DMF and filtered through a syringe filter. The filtrate was purified by reverse phase HPLC (water/acetonitrile/0.1% TFA) to provide the title compound. 1H NMR (400 MHz, CD3OD) δ 9.03 (s, 1H), 8.83 (d, J=2.02 Hz, 1H), 8.22 (d, J=2.02 Hz, 1H), 8.08 (dd, J=2.02, 8.08 Hz, 1H), 7.92 (d, J=8.59 Hz, 1H), 7.88 (d, J=8.08 Hz, 1H), 7.66 (dd, J=2.27, 8.84 Hz, 1H), 7.22 (d, J=4.04 Hz, 4H), 7.10-7.18 (m, 1H), 7.06 (d, J=1.52 Hz, 1H), 4.28 (s, 2H), 4.07 (s, 3H), 3.71 (s, 3H); MS m/e 539.1 [M+H]+.

Workup

  1. customThe solvent was evaporated in vacuo
  2. additionthe residue was diluted with DMF
  3. filtrationfiltered through a syringe
  4. filtrationfilter
  5. customThe filtrate was purified by reverse phase HPLC (water/acetonitrile/0.1% TFA)

Sources & evidence

ORD record
ord-a36432b6292e4dc787d4f0a8b52e411e
Source dataset
uspto-grants-2016_03
Patent number
US09284308B2

Reaction notes

Loading…